Open-Label Observational Study of a Topical Formulation of Calcium Spirulan Contained in a Defined Extract of the Microalga <i>Spirulina platensis</i> in the Treatment of Children with Molluscum Contagiosum

<div>Outcome after an average treatment time with Spirularin<sup>®</sup> VS cream twice daily of 4 months. Complete clearance refers to absence of any visible signs of active MC infections: patients with no complete clearance required additional or other treatment options. Percentages based on patients that were no lost to follow-up (<i>n</i> = 26).</div>

Dermatology Research and Practice

fig2

Figure 2

Figure 2: Open-Label Observational Study of a Topical Formulation of Calcium Spirulan Contained in a Defined Extract of the Microalga <i>Spirulina platensis</i> in the Treatment of Children with Molluscum Contagiosum 

Figure 2 | Open-Label Observational Study of a Topical Formulation of Calcium Spirulan Contained in a Defined Extract of the Microalga Spirulina platensis in the Treatment of Children with Molluscum Contagiosum 